肠壁积气预测评估研究:美国创伤外科协会多中心流行病学研究
该前瞻性多中心研究纳入127例肠壁积气患者,其中79例为良性病变,49例经手术探查或尸检证实为透壁性缺血(病理学肠壁积气)。多因素logistic回归显示,乳酸>2.0 mmol/L(OR 5.1,95%CI 1.3-19.5,P=0.018)、INR升高(OR 3.2,95%CI 1.1-9.6,P=0.031)、腹膜炎(OR 15.0,95%CI 2.9-78,P=0.001)和血红蛋白降低(OR 0.70,95%CI 0.50-0.97,P=0.031)是透壁性缺血的独立预测因素,AUC为0.90(95%CI 0.83-0.97)。作者建议对肠壁积气合并乳酸>2 mmol/L和/或腹膜炎的患者强烈考虑手术探查,并对合并小肠受累、CT示腹水、无动力性肠梗阻、贫血和高INR的患者高度怀疑坏死。
要点
- 肠壁积气患者乳酸>2.0 mmol/L的透壁性缺血OR为5.1(95%CI 1.3-19.5,P=0.018)。
- 腹膜炎是透壁性缺血的强预测因素,OR为15.0(95%CI 2.9-78,P=0.001)。
- INR升高(OR 3.2,95%CI 1.1-9.6,P=0.031)和血红蛋白降低(OR 0.70,95%CI 0.50-0.97,P=0.031)也是独立预测因素。
- 小肠肠壁积气患者透壁性缺血发生率高于结肠肠壁积气患者。
- 作者推荐对肠壁积气合并乳酸>2 mmol/L和/或腹膜炎的患者强烈考虑手术探查。
适用人群与场景
- 纳入127例肠壁积气患者,其中79例为良性病变,49例为病理学肠壁积气(手术探查或尸检证实透壁性缺血)。
诊断标准与关键阈值
- 病理学肠壁积气定义为手术探查或尸检时存在透壁性缺血。
- 预测透壁性缺血的独立因素包括:乳酸>2.0 mmol/L、INR升高、腹膜炎、血红蛋白降低。
- 多因素模型预测透壁性缺血的AUC为0.90(95%CI 0.83-0.97)。
处置流程与药物剂量
- 作者推荐对肠壁积气合并乳酸>2 mmol/L和/或腹膜炎的患者强烈考虑手术探查。
- 作者建议对肠壁积气合并小肠受累、CT示腹水、无动力性肠梗阻、贫血和高INR的患者高度怀疑坏死。
红旗征与不能漏的情况
- 乳酸>2.0 mmol/L、腹膜炎、INR升高、血红蛋白降低、无动力性肠梗阻、脓毒症、低血压、小肠肠壁积气。
研究设计与关键结果
- 研究为前瞻性多中心流行病学研究,3年期间纳入127例肠壁积气患者,其中49例为病理学肠壁积气。
- 单因素分析显示INR升高、血红蛋白降低、乳酸>2.0 mmol/L、无动力性肠梗阻、腹膜刺激征、脓毒症和低血压预测病理学肠壁积气;小肠肠壁积气患者透壁性缺血发生率高于结肠肠壁积气患者。
- 多因素logistic回归显示乳酸>2.0 mmol/L(OR 5.1,95%CI 1.3-19.5,P=0.018)、INR升高(OR 3.2,95%CI 1.1-9.6,P=0.031)、腹膜炎(OR 15.0,95%CI 2.9-78,P=0.001)和血红蛋白降低(OR 0.70,95%CI 0.50-0.97,P=0.031)是透壁性缺血的独立预测因素,AUC为0.90(95%CI 0.83-0.97)。
- 乳酸≥2.0 mmol/L和腹膜炎是既往回顾性研究与本研究共有的预测因素。
证据类型、等级与局限
- 证据类型:前瞻性多中心流行病学研究(预后研究,证据等级II;治疗研究,证据等级II)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对肠壁积气患者,若乳酸>2 mmol/L和/或存在腹膜炎,作者推荐强烈考虑手术探查。
- 对肠壁积气合并小肠受累、CT示腹水、无动力性肠梗阻、贫血和高INR的患者,作者建议高度怀疑肠坏死。
指南或共识出处
- 美国创伤外科协会(American Association for the Surgery of Trauma)多中心流行病学研究
提炼说明
- 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Our group has previously published a retrospective review defining variables predictive of transmural bowel ischemia in the setting of pneumatosis intestinalis (PI). We hypothesize this prospective study will confirm the findings of the retrospective review, enhancing legitimacy to the predictive factors for pathologic PI previously highlighted.
METHODS: Data were collected using the Research Electronic Data Capture. Forward logistic regression was utilized to identify independent predictors for pathologic PI. Statistical significance was defined as p ≤ 0.05.
RESULTS: During the 3-year study period, 127 patients with PI were identified. Of these, 79 had benign disease, and 49 pathologic PI defined by the presence of transmural ischemia during surgical exploration or autopsy. Laboratory values such as elevated international normalized ratio (INR), decreased hemoglobin, and a lactate value of greater than 2.0 mmol/L were predictive of pathologic PI, as well as clinical factors including adynamic ileus, peritoneal signs on physical examination, sepsis, and hypotension. The location was also a significant factor, as patients with small bowel PI had a higher incidence of transmural ischemia than colonic PI. On multiple logistic regression, lactate value of greater than 2.0 mmol/L (odds ratio, 5.1, 1.3-19.5; p = 0.018), elevated INR (odds ratio, 3.2, 1.1-9.6; p = 0.031), peritonitis (15.0, 2.9-78; p = 0.001), and decreased hemoglobin (0.70, 0.50-0.97, 0.031) remained significant predictors of transmural ischemia (area under the curve, 0.90; 0.83-0.97). A lactate value of 2.0 mmol/L or greater and peritonitis are common factors between the retrospective review and this prospective study.
CONCLUSIONS: We recommend surgical exploration to be strongly considered for those PI patients presenting also with a lactate greater than 2 mmol/L and/or peritonitis. We suggest strong suspicion for necrosis in those patient with PI and small bowel involvement, ascites on computed tomography scan, adynamic ileus, anemia, and a high INR.
LEVEL OF EVIDENCE: Prognostic study, level II; therapeutic study, level II.
参考来源
- Ferrada P, Callcut R, Bauza G, et al. Pneumatosis Intestinalis Predictive Evaluation Study: A multicenter epidemiologic study of the American Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2017. PMID: 28225738. doi:10.1097/TA.0000000000001360
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。